Skip to main content
68°
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Minerva Neuroscie
(NQ:
NERV
)
2.630
UNCHANGED
Streaming Delayed Price
Updated: 3:06 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Minerva Neuroscie
< Previous
1
2
3
4
5
6
Next >
Snowflake, Beazer Homes, Joby Aviation And Other Big Stocks Moving Higher On Wednesday
June 28, 2023
U.S. stocks traded lower, with the Dow Jones dropping over 100 points on Wednesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Dow Drops 100 Points; General Mills Posts Downbeat Sales
June 28, 2023
U.S. stocks traded lower this morning, with the Dow Jones dropping around 100 points on Wednesday. Following the market opening Wednesday, the Dow traded down 0.30% to 33,823.27 while the NASDAQ fell...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
June 28, 2023
Via
Benzinga
Minerva Neurosciences Announces $20 Million in Private Placement Priced at a Premium to Market
June 28, 2023
From
Minerva Neurosciences, Inc
Via
GlobeNewswire
Earnings Preview For Minerva Neurosciences
May 12, 2023
Via
Benzinga
Minerva Neurosciences Reports 2023 First Quarter Financial Results and Business Updates
May 15, 2023
Company to host conference call today at 8:30 a.m. ET
From
Minerva Neurosciences, Inc
Via
GlobeNewswire
Minerva Neurosciences Announces Update on its New Drug Application (NDA) for Roluperidone for the Treatment of Negative Symptoms in Schizophrenia
May 10, 2023
From
Minerva Neurosciences, Inc
Via
GlobeNewswire
Minerva Neurosciences to Report First Quarter 2023 Financial Results and Business Updates on May 15, 2023
May 08, 2023
Management to Host Conference Call
From
Minerva Neurosciences, Inc
Via
GlobeNewswire
Minerva Neurosciences Inc. (NASDAQ: NERV) Leading the Way in Monday Trading Based on Percentage Gain
May 01, 2023
Via
Investor Brand Network
Earnings Preview For Minerva Neurosciences
March 07, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
May 01, 2023
Via
Benzinga
Minerva Neurosciences Announces the NDA Filing for Roluperidone for the Treatment of Negative Symptoms in Schizophrenia
May 01, 2023
FDA grants appeal and files NDA
From
Minerva Neurosciences, Inc
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Intraday Session
April 26, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
April 11, 2023
Via
Benzinga
Minerva Neurosciences Reports Fiscal Year 2022 Fourth Quarter And Year End Financial Results And Business Updates
March 08, 2023
Company to Host Conference Call Today at 8:30 a.m. ET
From
Minerva Neurosciences, Inc
Via
GlobeNewswire
Earnings Scheduled For March 8, 2023
March 08, 2023
Companies Reporting Before The Bell • Daktronics (NASDAQ:DAKT) is expected to report quarterly earnings at $0.00 per share on revenue of $164.68 million.
Via
Benzinga
Minerva Neurosciences to Report Fiscal Year 2022 Financial Results and Business Updates on March 8, 2023
March 01, 2023
Management to Host Conference Call
From
Minerva Neurosciences, Inc
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
January 11, 2023
Via
Benzinga
EXCLUSIVE: The Benzinga Moneymaker Series, 5 Emerging Stocks For Investors To Watch
December 29, 2022
Investors are on the hunt for undervalued, underfollowed and emerging stocks to spot opportunities. The rise of social media and retail traders gave way to countless methods to uncover new information....
Via
Benzinga
Tesla, Amazon, Minerva, Kala Pharma, Gorilla Tech: Why These 5 Stocks Are Drawing Investors' Attention Today
December 28, 2022
Major Wall Street indices closed in the red on Wednesday as investors and traders lost optimism regarding any possible year-end rebound and braced themselves for the new year while lightening up on...
Via
Benzinga
Nasdaq Down 100 Points; Kala Pharmaceuticals Shares Spike Higher
December 28, 2022
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping around 100 points on Wednesday.
Via
Benzinga
Why Shares Of Chinese Companies Are Trading Lower? Here Are 54 Stocks Moving In Wednesday's Mid-Day Session
December 28, 2022
Gainers Kala Pharmaceuticals, Inc. (NASDAQ: KALA) shares gained 130.5% to $9.03 after the company announced FDA acceptance of a IND application for its KPI-012 for the treatment of persistent corneal...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
December 28, 2022
Via
Benzinga
Dow Tumbles 150 Points; Crude Oil Falls Sharply
December 28, 2022
U.S. stocks turned lower midway through trading, with the Dow Jones dropping around 150 points on Wednesday.
Via
Benzinga
US Stocks Rise; Dow Gains 100 Points
December 28, 2022
U.S. stocks traded higher this morning, with the Dow Jones gaining over 100 points on Wednesday.
Via
Benzinga
Minerva Neurosciences Announces Update on its New Drug Application (NDA) for Roluperidone for the Treatment of Negative Symptoms in Schizophrenia
December 28, 2022
From
Minerva Neurosciences, Inc
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
December 06, 2022
Gainers
Via
Benzinga
Greater Prevalence of Anxiety & Depressive Disorders Driving Demand for New Anti-Anxiety Drug Candidates
November 14, 2022
EQNX::TICKER_START (NASDAQ:SAGE),NASDAQ:NERV),(NASDAQ:ATAI),(NYSE:CYBN),(TSXV:MRVL),(NEO:CYBN), EQNX::TICKER_END
Via
FinancialNewsMedia
Topics
Retirement
Exposures
Pension
Product Safety
Benzinga's Top Ratings Upgrades, Downgrades For November 10, 2022
November 10, 2022
Upgrades
Via
Benzinga
Minerva Neurosciences Reports Third Quarter 2022 Financial Results and Business Updates
November 09, 2022
Company To Host Live Webcast Today at 8:30 a.m. ET
From
Minerva Neurosciences, Inc
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.